Industry insights


Display Industry Insights related to containing

Showing 222 results

    Added 9th October 2015

    Big Data, Wider Mindset

    Big data describes the unprecedented and growing amounts of ‘omics' data that are becoming available via high-throughput technologies. Using those data to improve the outcomes of existing workflows in pharmaceutical ...

    Added 8th October 2015

    The Perfect Gatekeeper

    Companion diagnostics identify patients who will benefit from a targeted medication. As gatekeepers of such therapy decisions, a strong, safe and effective companion diagnostic is at the core of precision ...

    Added 30th September 2015

    The Perfect Gatekeeper Form

    Get access to the complimentary scientific paper from Pharma & Life Sciences section "The Perfect Gatekeeper" from Elsevier R&D Solutions. ...

    Added 29th September 2015

    The Patient in the Middle Point

    A turning point in oncology and the development of cancer medications is unfolding and Dr. Jean Cui is in the forefront of unprecedented changes. She explains that the patient now ...

    Added 29th September 2015

    Not Easier, But Better Drugs

    Ideas to shift drug development to processes based on network biology and polypharmacology are an increasingly relevant topic in the scientific literature. Dr. Scott Lusher, an expert on leveraging “big ...

    Added 29th September 2015

    Powerful Tools and a New Mindset

    Is it time to step back from looking at single compounds interact with single targets and integrate a broader perspective into drug development that encompasses the complex molecular networks of ...

    Added 29th September 2015

    Finding the Right Patient for Your Drug

    A test to predict which patients will most likely benefit from a drug can greatly magnify its therapeutic efficacy. The development of that companion diagnostic should begin early and build ...

    Added 9th September 2015

    Exploring Autophagy in Cancer with Pathway Studio

    In this new case study, Dr. Philip Lorenzi, Supervisor, Laboratory and Research and Co-Director, Proteomics and Metabolomics Core Facility at MD Anderson Cancer Center, discusses the different ways that research ...

    Added 9th September 2015

    A pharmacovigilance paradise?

    A pharmacovigilance paradise? The second listing, let’s call it the ICSR listing, has two versions. ...

    Added 9th September 2015

    EMA’s Medical Literature Monitoring: Shakedown or Shakeup

    EMA may have started, surely by accident, a small revolution, in the medical bibliographic information ecosystem. ...